Skip to main content
Today · Plain-English health journalism — fact-checked, ad-free, and free for everyone. · Every claim cited to the evidence.
Sleep & Recovery

Melatonin: What It Actually Does, the Doses Studied, and Why Most Products Have 10× Too Much

Melatonin is a circadian timing signal, not a sedative. The evidence is strongest for jet lag, shift work and delayed sleep timing; effects on garden-variety insomnia are small. In the best-known dose trial, 0.3mg worked as well as 3mg, yet most products contain 3-10mg. Here’s what the research says about why more isn’t better.

Share: 𝕏 f in ✉
Melatonin: What It Actually Does, the Doses Studied, and Why Most Products Have 10 Too Much

The 60-second version

Melatonin is the most widely-used and most widely-misunderstood sleep supplement. The published evidence: melatonin is a circadian-timing signal, not a sedative. It tells the brain “it’s night” rather than directly producing sleepiness. The implications are practical: melatonin’s best evidence is for circadian-misalignment problems (jet lag, shift work, delayed sleep phase), and its effects on garden-variety insomnia, where circadian timing isn’t the issue, are small. In the best-known dose trial, 0.3mg — roughly the body’s own night-time level — worked as well as 3mg, while most commercial products contain 3-10mg. Higher doses can leave melatonin circulating into the morning, which may explain the next-day grogginess some people report. For circadian problems, timing matters as much as dose, and the right timing is individual. For chronic insomnia not driven by circadian issues, cognitive-behavioural therapy for insomnia (CBT-I), available through your clinician or a structured program, has stronger and more durable evidence than melatonin.

Educational journalism, not medical advice. Every claim here is checked against its cited sources by editor Timothy Bunce — a health writer, not a physician. It isn’t specific to your situation: for health decisions, talk to your own clinician. How we work →

Some links in this article are affiliate links. If you buy through one, The Beachside Reader earns a commission at no extra cost to you. It never changes which products we pick, or what we say about them. Full affiliate disclosure →

What melatonin actually does

Melatonin is a hormone produced by the pineal gland, secretion rising in the evening as ambient light drops and peaking in the middle of the night. Its primary role is signalling the timing of biological night to every cell in the body — not producing sleep directly. The sleepiness people associate with melatonin is downstream of this timing signal, not the primary effect.

This distinction explains the trial results. Melatonin produces:

Why more isn’t better: 0.3mg vs 3-10mg

In dose studies, about 0.3mg taken by mouth produced blood levels close to the body’s natural night-time peak. Higher doses produce supraphysiological levels — concentrations many times higher than the body produces naturally. Two possible problems follow:

A landmark trial in older adults with age-related insomnia tested 0.1mg, 0.3mg, and 3.0mg doses against placebo: the 0.3mg dose — which raises blood melatonin to the level the body produces naturally at night — restored sleep efficiency, while the 3.0mg dose left melatonin circulating into daylight hours and induced hypothermia, with no added sleep benefit over the 0.3mg dose Zhdanova 2001. The 3-10mg products that dominate the retail shelf contain roughly 10-30 times the 0.3mg dose that performed best in that trial.

Timing matters

For circadian problems, timing matters as much as dose: melatonin shifts the body clock in different directions depending on when it’s taken, and taken at the wrong time it can shift the clock the wrong way. What the research covers:

What melatonin doesn’t do

When CBT-I beats melatonin

For chronic insomnia (persistent sleep problems lasting weeks/months), cognitive-behavioural therapy for insomnia has a much stronger evidence base than melatonin, and its benefits tend to persist after treatment ends. CBT-I addresses the cognitive and behavioural patterns that maintain insomnia (clock-watching, in-bed wakefulness, anticipatory anxiety about sleep). It’s the recommended first-line treatment for chronic insomnia in clinical guidelines, so if sleep problems have lasted more than a few weeks, talk to your family doctor rather than relying on a supplement.

Practical takeaways

Frequently asked questions

How much melatonin should I take?

That’s a question for your pharmacist or clinician, who can take your age, health and other medications into account. What the research shows: in the best-known dose trial, 0.3mg — close to the body’s own night-time level — improved sleep as well as 3mg, while 3mg left melatonin circulating into the daytime. Most commercial products contain 3-10mg. Health Canada-authorised melatonin labels advise against use during pregnancy or breastfeeding.

Is melatonin addictive?

Not in the traditional sense — it isn’t known to cause physical dependence or withdrawal. Laboratory research suggests chronically high levels can desensitise melatonin receptors, but whether that reduces its effect in people over weeks of use isn’t well established.

Does melatonin help me stay asleep?

Less so than for falling asleep. Middle-of-night awakening has different drivers (cortisol, autonomic balance, anxiety, sleep environment). For sleep maintenance issues, look at evening alcohol, late-evening eating, room temperature, and stress regulation. If night waking persists, or comes with loud snoring or gasping, raise it with your doctor.

Should I take melatonin every night?

Probably not. The evidence is strongest for short-term use during circadian adjustments (jet lag, shift work, phase delay), and long-term nightly use is less well studied. If you feel you need something every night, that’s worth discussing with your doctor: persistent insomnia is treatable, and CBT-I is the recommended first-line approach.

Is melatonin safe for kids?

Short-term use under medical guidance has reasonable safety data. Long-term use in children is poorly studied and the puberty-onset concerns from animal data haven’t been definitively resolved. Don’t use without a pediatrician’s involvement.

References

Ferracioli-Oda 2013Ferracioli-Oda E, Qawasmi A, Bloch MH. Meta-analysis: melatonin for the treatment of primary sleep disorders. PLoS One. 2013;8(5):e63773. View source →
Zhdanova 2001Zhdanova IV, Wurtman RJ, Regan MM, Taylor JA, Shi JP, Leclair OU. Melatonin treatment for age-related insomnia. J Clin Endocrinol Metab. 2001;86(10):4727-4730. View source →

Related reading